Skip to main content
SpringerLink
Log in

Calciotropic Hormones

  • Chapter
Osteoporosis in Older Persons

The calcium—vitamin D—parathyroid hormone (PTH) system plays a critical role in both health and disease. Despite longstanding acceptance of its importance in maintaining the skeleton, recent and accumulating data have significantly enhanced our understanding of the pathophysiology of cal-ciotropic hormones in the setting of osteoporosis. Herein we review this information and make recommendations based on these studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ramasamy I. Recent advances in physiological calcium homeostasis. Clin Chem Lab Med 2006; 44(3):237–273.

    CAS  PubMed  Google Scholar 

  2. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92(1):4–8.

    CAS  PubMed  Google Scholar 

  3. Holick MF. The vitamin d epidemic and its health consequences. J Nutr 2005;135(11):2739S– 2748S.

    CAS  PubMed  Google Scholar 

  4. Nordin BE, Need AG, Morris HA, et al. Effect of age on calcium absorption in postmenopausal women. Am J Clin Nutr 2004;80(4):998–1002.

    CAS  PubMed  Google Scholar 

  5. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289(1):F8–F28.

    CAS  PubMed  Google Scholar 

  6. Troen BR. The role of cathepsin K in normal bone resorption. Drug News Perspect 2004;17(1):19–28.

    CAS  PubMed  Google Scholar 

  7. Anderson PH, O'Loughlin PD, May BK, et al. Determinants of circulating 1,25-dihydroxyvita-min D3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 2004;89–90(1–5):111–113.

    PubMed  Google Scholar 

  8. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116(8):2062–2072.

    CAS  PubMed  Google Scholar 

  9. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135(2):317–322.

    CAS  PubMed  Google Scholar 

  10. Matsuoka LY, Wortsman J, Hollis BW. Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol 1990;22(5 Pt 1):772–775.

    CAS  PubMed  Google Scholar 

  11. Clemens TL, Adams JS, Henderson SL, et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 1(8263):74–76.

    CAS  PubMed  Google Scholar 

  12. Matsuoka LY, Wortsman J, Haddad JG, et al. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991;127(4): 536–538.

    CAS  PubMed  Google Scholar 

  13. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76(4):1536–1538.

    CAS  PubMed  Google Scholar 

  14. Grieger JA, Nowson CA. Nutrient intake and plate waste from an Australian residential care facility. Eur J Clin Nutr 2007;61(5):655–663.

    CAS  PubMed  Google Scholar 

  15. Dumartheray EW, Krieg MA, Cornuz J, Whittamore DR, Lanham-New SA, Burckhardt P. Energy and nutrient intake of Swiss women aged 75–87 years. J Hum Nutr Diet 2006;19:431–435.

    PubMed  Google Scholar 

  16. Avioli LV. Postmenopausal osteoporosis: prevention versus cure. Fed Proc 1981;40(9):2418–2422.

    CAS  PubMed  Google Scholar 

  17. Gennari C. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr 2001;4(2B):547–559.

    CAS  PubMed  Google Scholar 

  18. Shahar D, Shai I, Vardi H, et al. Factors associated with low reported energy intake in the elderly. J Nutr Health Aging 2005;9(5):300–304.

    CAS  PubMed  Google Scholar 

  19. French MR, Moore K, Vernace-Inserra F, et al. Factors that influence adherence to calcium recommendations. Can J Diet Pract Res 2005; 66(1):25–29.

    PubMed  Google Scholar 

  20. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90(6): 3215–3224.

    CAS  PubMed  Google Scholar 

  21. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97(1–2):13–19.

    CAS  PubMed  Google Scholar 

  22. Harinarayan CV. Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int 2005;16(4):397–402.

    CAS  PubMed  Google Scholar 

  23. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7(5):439–443.

    CAS  PubMed  Google Scholar 

  24. Vecino-Vecino C, Gratton M, Kremer R, et al. Seasonal variance in serum levels of vitamin d determines a compensatory response by parathyroid hormone: study in an ambulatory elderly population in Quebec. Gerontology 2006;52(1):33–39.

    CAS  PubMed  Google Scholar 

  25. Nakamura K, Nishiwaki T, Ueno K, et al. Serum 25-hydroxyvitamin D levels and activities of daily living in noninstitutionalized elderly Japanese requiring care. J Bone Miner Metab 2005;23(6): 488–494.

    CAS  PubMed  Google Scholar 

  26. Levis S, Gomez A, Jimenez C, et al. Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab 2005;90(3):1557–1562.

    CAS  PubMed  Google Scholar 

  27. Kudlacek S, Schneider B, Peterlik M, et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003;33(4): 323–331.

    CAS  PubMed  Google Scholar 

  28. Meier C, Woitge HW, Witte K, et al. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19(8):1221–1230.

    CAS  PubMed  Google Scholar 

  29. Dawodu A, Absood G, Patel M, et al. Biosocial factors affecting vitamin D status of women of childbearing age in the United Arab Emirates. J Biosoc Sci 1998;30(4):431–437.

    CAS  PubMed  Google Scholar 

  30. Dawodu A, Dawson KP, Amirlak I, et al. Diet, clothing, sunshine exposure and micronutrient status of Arab infants and young children. Ann Trop Paediatr 2001;21(1):39–44.

    CAS  PubMed  Google Scholar 

  31. Gannage-Yared MH, Chemali R, Yaacoub N, et al. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 2000;15(9):1856–1862.

    CAS  PubMed  Google Scholar 

  32. Guzel R, Kozanoglu E, Guler-Uysal F, et al. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 2001;10(8):765–770.

    CAS  PubMed  Google Scholar 

  33. Islam MZ, Akhtaruzzaman M, Lamberg-Allardt C. Hypovitaminosis D is common in both veiled and nonveiled Bangladeshi women. Asia Pac J Clin Nutr 2006;15(1):81–87.

    CAS  PubMed  Google Scholar 

  34. Harris SS. Vitamin D and African Americans. J Nutr 2006;136(4):1126–1129.

    CAS  PubMed  Google Scholar 

  35. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116(9):634–639.

    CAS  PubMed  Google Scholar 

  36. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr 2004;80(6 Suppl):1763S–1766S.

    CAS  PubMed  Google Scholar 

  37. Aloia JF, Talwar SA, Pollack S, et al. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med 2005;165(14):1618–1623.

    CAS  PubMed  Google Scholar 

  38. Parfitt AM. Osteomalacia and related disorders. In: Metabolic bone disease and clinical related disorders, 2nd edition.Avioli LV, Krane SM, eds. Philadelphia: Saunders, 1990; 329–396.

    Google Scholar 

  39. Heaney RP. Lessons for nutritional science from vitamin D. Am J Clin Nutr 1999;69(5):825–826.

    CAS  PubMed  Google Scholar 

  40. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291(16):1999–2006.

    CAS  PubMed  Google Scholar 

  41. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp Res 2005;17(2):125–132.

    CAS  PubMed  Google Scholar 

  42. Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med 2005;118(11): 1190–1195.

    PubMed  Google Scholar 

  43. Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004;19(2):265–269.

    CAS  PubMed  Google Scholar 

  44. Kitazawa R, Kitazawa S. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem Biophys Res Commun 2002;290(2): 650–655.

    CAS  PubMed  Google Scholar 

  45. Liang CT, Barnes J, Imanaka S, et al. Alterations in mRNA expression of duodenal 1,25-dihydroxyvitamin D3 receptor and vitamin D-dependent calcium binding protein in aged Wistar rats. Exp Gerontol 1994;29(2):179–186.

    CAS  PubMed  Google Scholar 

  46. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337(10):670–676.

    CAS  PubMed  Google Scholar 

  47. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326(7387): 469.

    CAS  PubMed  Google Scholar 

  48. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327(23): 1637–1642.

    CAS  PubMed  Google Scholar 

  49. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13(3):257–264.

    CAS  PubMed  Google Scholar 

  50. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330(7498): 1003.

    CAS  PubMed  Google Scholar 

  51. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365(9471):1621–1628.

    CAS  PubMed  Google Scholar 

  52. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293(18):2257–2264.

    CAS  PubMed  Google Scholar 

  53. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354(7):669–683.

    CAS  PubMed  Google Scholar 

  54. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 2004;80(3):752–758.

    CAS  PubMed  Google Scholar 

  55. Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005;53(11):1881–1888.

    PubMed  Google Scholar 

  56. Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004;33(6):589–595.

    PubMed  Google Scholar 

  57. Pfeifer M, Dobnig H, Begerow B, Suppan K. Effects of vitamin D and calcium supplementation on falls and parameters of muscle function—a prospective, randomized, double-blind, multi-center study. J Bone Miner Res 2004.

    Google Scholar 

  58. Wicherts IS, Schoor van NM, Boeke AJP, Lips P. Vitamin D deficiency and neuromuscular performance in the Longitudinal Aging Study Amsterdam (LASA). J Bone Miner Res 2005.

    Google Scholar 

  59. Kenny AM, Biskup B, Robbins B, et al. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 2003;51(12): 1762–1767.

    PubMed  Google Scholar 

  60. Latham NK, Anderson CS, Lee A, et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 2003;51(3):291–299.

    PubMed  Google Scholar 

  61. Law M, Withers H, Morris J, et al. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006; 35(5):482–486.

    PubMed  Google Scholar 

  62. Judge JO, Kenny A. Vitamin D and quadriceps exercise—got milk? Got a chair? J Am Geriatr Soc 2003;51(3):427–428.

    PubMed  Google Scholar 

  63. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96(2):252–261.

    PubMed  Google Scholar 

  64. Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 2006;92(1):65–79.

    CAS  PubMed  Google Scholar 

  65. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941;1:191–195.

    Google Scholar 

  66. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9(3):227–231.

    CAS  PubMed  Google Scholar 

  67. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006;26(4A):2687–2699.

    CAS  PubMed  Google Scholar 

  68. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 2005;10(2):94–111.

    PubMed  Google Scholar 

  69. Howard GA, Turner RT, Sherrard DJ, et al. Human bone cells in culture metabolize 25-hydroxyvita-min D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 1981; 256(15):7738–7740.

    CAS  PubMed  Google Scholar 

  70. Hewison M, Zehnder D, Bland R, et al. 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol 2000;25(2):141–148.

    CAS  PubMed  Google Scholar 

  71. Zehnder D, Bland R, Williams MC, et al. Extrare-nal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86(2):888–894.

    CAS  PubMed  Google Scholar 

  72. Bareis P, Bises G, Bischof MG, et al. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 2001;285(4):1012–1017.

    CAS  PubMed  Google Scholar 

  73. Zinser GM, Tribble E, Valrance M, et al. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors. Anticancer Res 2005;25(1A):235–241.

    CAS  PubMed  Google Scholar 

  74. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;1(8): 1164–1169.

    Google Scholar 

  75. Berube S, Diorio C, Verhoek-Oftedahl W, et al. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004;13(9):1466–1472.

    CAS  PubMed  Google Scholar 

  76. Moon S, Holley S, Bodiwala D, et al. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer. Ann Hum Genet 2006;70(Pt 2):226–236.

    CAS  PubMed  Google Scholar 

  77. Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem 2004;92(3):436– 444.

    CAS  PubMed  Google Scholar 

  78. Kricker A, Armstrong B. Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol 2006;92(1):132–139.

    CAS  PubMed  Google Scholar 

  79. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28(5):1228–1230.

    CAS  PubMed  Google Scholar 

  80. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia 2005;48(7):1247– 1257.

    CAS  PubMed  Google Scholar 

  81. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79(5):820–825.

    CAS  PubMed  Google Scholar 

  82. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72(3):690–693.

    CAS  PubMed  Google Scholar 

  83. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90(7):4119–4123.

    CAS  PubMed  Google Scholar 

  84. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarco-penia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88(12):5766–5772.

    CAS  PubMed  Google Scholar 

  85. Visser M, Deeg DJ, Puts MT, et al. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006;84(3):616–622; quiz 671–672.

    CAS  PubMed  Google Scholar 

  86. Hayes CE, Nashold FE, Spach KM, et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49(2):277–300.

    CAS  Google Scholar 

  87. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97(1–2):93–101.

    PubMed  Google Scholar 

  88. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006;92(1):60–64.

    CAS  PubMed  Google Scholar 

  89. Harris SS. Vitamin D in type 1 diabetes prevention. J Nutr 2005;135(2):323–325.

    CAS  PubMed  Google Scholar 

  90. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005;19(9): 1067–1077.

    CAS  PubMed  Google Scholar 

  91. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocri-nol Metab 2001;86(4):1633–1637.

    CAS  Google Scholar 

  92. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103(3): 197–207.

    CAS  PubMed  Google Scholar 

  93. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41(1):105–112.

    CAS  PubMed  Google Scholar 

  94. Sanders JL, Stern PH. Protein kinase C involvement in interleukin-6 production by parathyroid hormone and tumor necrosis factor-alpha in UMR-106 osteoblastic cells. J Bone Miner Res 2000;15(5):885–893.

    CAS  PubMed  Google Scholar 

  95. Wu Y, Kumar R. Parathyroid hormone regulates transforming growth factor beta1 and beta2 synthesis in osteoblasts via divergent signaling pathways. J Bone Miner Res 2000;15(5):879–884.

    CAS  PubMed  Google Scholar 

  96. Troen BR. Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol 2003;38(6):605–614.

    CAS  PubMed  Google Scholar 

  97. Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26(5):688–703.

    CAS  PubMed  Google Scholar 

  98. Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980;280(6228): 1340–1344.

    CAS  PubMed  Google Scholar 

  99. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344(19): 1434–1441.

    CAS  PubMed  Google Scholar 

  100. Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003;18(1):9–17.

    CAS  PubMed  Google Scholar 

  101. Lane NE, Sanchez S, Modin GW, et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 1998;102(8): 1627–1633.

    CAS  PubMed  Google Scholar 

  102. Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001;16(10): 1846–1853.

    CAS  PubMed  Google Scholar 

  103. Uusi-Rasi K, Semanick LM, Zanchetta JR, et al. Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 2005;36(6): 948–958.

    CAS  PubMed  Google Scholar 

  104. Hagino H, Okano T, Akhter MP, et al. Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia. J Bone Miner Metab 2001;19(4):244–250.

    CAS  PubMed  Google Scholar 

  105. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 2003;88(1):185–191.

    CAS  PubMed  Google Scholar 

  106. Souberbielle JC, Cormier C, Kindermans C, et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001;86(7):3086–3090.

    CAS  PubMed  Google Scholar 

  107. Mosekilde L, Hermann AP, Beck-Nielsen H, et al. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999; 31(3):207–219.

    CAS  PubMed  Google Scholar 

  108. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338(12):777–783.

    CAS  PubMed  Google Scholar 

  109. Tangpricha V, Pearce EN, Chen TC, et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112(8):659–662.

    CAS  PubMed  Google Scholar 

  110. Maggio D, Cherubini A, Lauretani F, et al. 25(OH)D Serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A Biol Sci Med Sci 2005;60(11): 1414–1419.

    PubMed  Google Scholar 

  111. Lips P. Vitamin D deficiency and secondary hyper-parathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22(4):477–501.

    CAS  PubMed  Google Scholar 

  112. Sahota O, Gaynor K, Harwood RH, Hosking DJ. Hypovitaminosis D and “functional hypoparathy-roidism”—the NoNoF (Nottingham Neck of Femur) study. Age Ageing 2001;30(6):467–472.

    CAS  PubMed  Google Scholar 

  113. Sahota O, Mundey MK, San P, et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35(1):312– 319.

    CAS  PubMed  Google Scholar 

  114. Deplas A, Debiais F, Alcalay M, et al. Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects. J Nutr Health Aging 2004;8(5):400–404.

    CAS  PubMed  Google Scholar 

  115. Sakuma M, Endo N, Oinuma T, et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17(11):1608–1614.

    CAS  PubMed  Google Scholar 

  116. Fisher AA, Davis MW. Calcium-PTH-vitamin D axis in older patients with hip fracture. Osteopo-ros Int 2007;18(5):693–695.

    CAS  Google Scholar 

  117. Sahota O, Mundey MK, San P, et al. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006;17(7):1013–1021.

    CAS  PubMed  Google Scholar 

  118. Heaney RP. Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior. J Endocrinol Invest 2005;28(2):180–182.

    CAS  PubMed  Google Scholar 

  119. Vieth R, El-Hajj Fuleihan G. There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J Endocrinol Invest 2005;28(2):183–186.

    CAS  PubMed  Google Scholar 

  120. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294(18):2336–2341.

    CAS  PubMed  Google Scholar 

  121. Ledger GA, Burritt MF, Kao PC, et al. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab 1995;80(11):3304–3310.

    CAS  PubMed  Google Scholar 

  122. Kennel KA, Riggs BL, Achenbach SJ, et al. Role of parathyroid hormone in mediating age-related changes in bone resorption in men. Osteoporos Int 2003;14(8):631–636.

    CAS  PubMed  Google Scholar 

  123. Blain H, Vuillemin A, Blain A, et al. Age-related femoral bone loss in men: evidence for hyperpara-thyroidism and insulin-like growth factor-1 deficiency. J Gerontol A Biol Sci Med Sci 2004; 59(12):1285–1289.

    PubMed  Google Scholar 

  124. Findlay DM, Sexton PM. Calcitonin. Growth Factors 2004;22(4):217–224.

    CAS  PubMed  Google Scholar 

  125. Miller S. Calcitonin—guardian of the Mammalian skeleton or is it just a fish story? Endocrinology 2006;147(9):4007–4009.

    CAS  PubMed  Google Scholar 

  126. Cappelli C, Cottarelli C, Cumetti D, et al. [Bone density and mineral metabolism in calcitonin-deficiency patients]. Minerva Endocrinol 2004; 29(1):1–10.

    CAS  PubMed  Google Scholar 

  127. Woodrow JP, Sharpe CJ, Fudge NJ, et al. Calcito-nin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 2006;147(9):4010–4021.

    CAS  PubMed  Google Scholar 

  128. Grant WB, Gorham ED. Commentary: time for public health action on vitamin D for cancer risk reduction. Int J Epidemiol 2006;35(2):224– 225.

    PubMed  Google Scholar 

  129. Diamond TH, Ho KW, Rohl PG, et al. Annual intramuscular injection of a megadose of chole-calciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183(1): 10–12.

    PubMed  Google Scholar 

  130. Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D. Am J Clin Nutr 2007;85(1): 6–18.

    CAS  PubMed  Google Scholar 

  131. Ishijima M, Yamanaka M, Sakamoto Y, et al. Vitamin D insufficiency impairs the effect of alendronate for the treatment of osteoporosis in postmenopausal women. J Bone Miner Res 2005; 20(Suppl 1):S296.

    Google Scholar 

  132. Ish-Shalom S, Salganik T, Segal E, et al. Daily, weekly or monthly protocols to reach the desired serum 25-hydroxyvitamin D concentration for the elderly. J Bone Miner Res 2005;20(Suppl 1): S288.

    Google Scholar 

  133. Mocanu V, Stitt PA, Costan A, et al. Safety and bone mineral density effects of bread fortified with 125 mcg vitamin D3/day in romanian nursing-home residents. J Bone Miner Res 2005;20 (Suppl 1):S288.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geriatric Research Education and Clinical Center, Research Service, Miami Veterans Affairs Medical Center, Geriatrics Institute and Division of Gerontology and Geriatrics, Miller School of Medicine, University of Miami, Miami, FL, USA

    E. Paul Cherniack MD

  2. Geriatric Research Education and Clinical Center Research Service, Miami Veterans Affairs Medica Center, Geriatrics Institute and Division of Gerontology and Geriatrics, Miller School of Medicine, University of Miami, Miami, FL, USA

    Bruce R. Troen MD

Authors
  1. E. Paul Cherniack MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce R. Troen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Geriatric Medicine-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada

    Gustavo Duque

  2. Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA

    Douglas P. Kiel

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Cherniack, E.P., Troen, B.R. (2009). Calciotropic Hormones. In: Duque, G., Kiel, D.P. (eds) Osteoporosis in Older Persons. Springer, London. https://doi.org/10.1007/978-1-84628-697-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-697-1_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-515-8

  • Online ISBN: 978-1-84628-697-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation